132 research outputs found
Π‘ΠΈΠΌΠ²ΠΎΠ»ΡΠΊΠ° ΠΊΠΎΡΡΡΠΌΡ ΡΠΊ ΠΎΠ±ΡΠ°Π·Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΡ ΠΌΠ΅ΡΠ°ΡΠΎΡΠΈ Π² ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΡ Π΅ΡΠ½ΡΡΠ½ΠΈΡ Π΄Π΅ΡΡΠ½ΡΡΡΠΉ ΠΡΠ΄ΠΌΠΈΠ»ΠΈ Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ
The article is the result of an art study of the author's clothing series by artist Liudmyla Semykina. The main focus of this work is analysis of the image-plastic symbolism of the clothing in the context of ethnic definitions, as well as the mythopoetic reconstructions of Scythian-Sarmatian and ancient Russian attire. The author's reading of the sacral, aesthetic, functional tasks of the costume became, in fact, a plastic embodiment of the artist's spiritual credo, which made it possible to draw parallels with the ancient cultures that influenced the formation of the megacultural context of modern Ukraine. A comprehensive analysis of the collection of L. Semykina's clothing revealed the peculiarities of the artist's plastic and plastic worldview, the nature of the formal techniques inherent in her artistic manner. The problem of synthesis of design, plastic and color solution of the structures is considered, where L. Semykina acts in the positions of theorist, artist, designerΠ‘ΡΠ°ΡΡΡ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠΌ ΠΈΡΠΊΡΡΡΡΠ²ΠΎΠ²Π΅Π΄ΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π°Π²ΡΠΎΡΡΠΊΠΎΠΉ ΡΠ΅ΡΠΈΠΈ ΠΎΠ΄Π΅ΠΆΠ΄Ρ Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΡΡ ΠΡΠ΄ΠΌΠΈΠ»Ρ Π‘Π΅ΠΌΡΠΊΠΈΠ½ΠΎΠΉ. ΠΡΠ½ΠΎΠ²Π½ΡΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ ΡΠ²Π»ΡΠ΅ΡΡΡ Π°Π½Π°Π»ΠΈΠ· ΠΎΠ±ΡΠ°Π·Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠΌΠ²ΠΎΠ»ΠΈΠΊΠΈ ΠΊΠΎΡΡΡΠΌΠ° Π² ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΠ΅ ΡΡΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄Π΅ΡΠΈΠ½ΠΈΡΠΈΠΉ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΌΠΈΡΠΎΠΏΠΎΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΉ ΡΠΊΠΈΡΠΎ-ΡΠ°ΡΠΌΠ°ΡΡΠΊΠΈΡ
ΠΈ Π΄ΡΠ΅Π²Π½Π΅ΡΡΡΡΠΊΠΈΡ
ΠΊΠΎΡΡΡΠΌΠΎΠ². ΠΠ²ΡΠΎΡΡΠΊΠΎΠ΅ ΠΏΡΠΎΡΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠ°Π»ΡΠ½ΡΡ
, ΡΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
, ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π·Π°Π΄Π°Ρ ΠΊΠΎΡΡΡΠΌΠ° ΡΡΠ°Π»ΠΎ, ΠΏΠΎ ΡΡΡΠΈ, ΠΏΠ»Π°ΡΡΠΈΡΠ½ΡΠΌ Π²ΠΎΠΏΠ»ΠΎΡΠ΅Π½ΠΈΠ΅ΠΌ Π΄ΡΡ
ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΊΡΠ΅Π΄ΠΎ Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΡΡ, ΡΠ΄Π΅Π»Π°Π»ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠΌ Β ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠ°Π»Π»Π΅Π»Π΅ΠΉ Ρ Π΄ΡΠ΅Π²Π½ΠΈΠΌΠΈ ΠΊΡΠ»ΡΡΡΡΠ°ΠΌΠΈ, ΠΏΠΎΠ²Π»ΠΈΡΠ²ΡΠΈΠΌΠΈ Π½Π° ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ΅Π³Π°ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΠ° ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π£ΠΊΡΠ°ΠΈΠ½Ρ. ΠΠ½Π°Π»ΠΈΠ· ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΈ ΠΊΠΎΡΡΡΠΌΠΎΠ² Π. Π‘Π΅ΠΌΡΠΊΠΈΠ½ΠΎΠΉ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» Π²ΡΡΠ²ΠΈΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Ρ
ΡΠ΄ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠΈΡΠΎΠ²ΠΎΡΠΏΡΠΈΡΡΠΈΡ Π°Π²ΡΠΎΡΠ°, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΡΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ
ΠΏΡΠΈΠ΅ΠΌΠΎΠ², ΡΠ²ΠΎΠΉΡΡΠ²Π΅Π½Π½ΡΡ
Π΅Π΅ Ρ
ΡΠ΄ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΌΠ°Π½Π΅ΡΠ΅. Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΠΊΠΆΠ΅ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΡΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΡΠΈΠ½ΡΠ΅Π·Π° ΠΏΡΠΎΠ΅ΠΊΡΠ½ΠΎΠ³ΠΎ, ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈ ΡΠ²Π΅ΡΠΎΠ²ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΊΠΎΡΡΡΠΌΠ°, Π³Π΄Π΅ Π. Π‘Π΅ΠΌΡΠΊΠΈΠ½Π° Π²ΡΡΡΡΠΏΠ°Π΅Ρ Π² ΠΈΠΏΠΎΡΡΠ°ΡΡΡ
ΡΠ΅ΠΎΡΠ΅ΡΠΈΠΊΠ°, Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΠΊΠ°, Π΄ΠΈΠ·Π°ΠΉΠ½Π΅ΡΠ°, ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΎΡΠ°Π‘ΡΠ°ΡΡΡ Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠΌ ΠΌΠΈΡΡΠ΅ΡΡΠ²ΠΎΠ·Π½Π°Π²ΡΠΎΠ³ΠΎ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π°Π²ΡΠΎΡΡΡΠΊΠΎΡ ΡΠ΅ΡΡΡ ΠΎΠ΄ΡΠ³Ρ Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΡΡ ΠΡΠ΄ΠΌΠΈΠ»ΠΈ Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ. ΠΡΠ½ΠΎΠ²Π½ΠΈΠΌ Π½Π°ΠΏΡΡΠΌΠΊΠΎΠΌ Π΄Π°Π½ΠΎΡ ΡΠΎΠ±ΠΎΡΠΈ Ρ Π°Π½Π°Π»ΡΠ· ΠΎΠ±ΡΠ°Π·Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΡ ΡΠΈΠΌΠ²ΠΎΠ»ΡΠΊΠΈ ΠΊΠΎΡΡΡΠΌΡ Π² ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΡ Π΅ΡΠ½ΡΡΠ½ΠΈΡ
Π΄Π΅ΡΡΠ½ΡΡΡΠΉ, Π° ΡΠ°ΠΊΠΎΠΆ ΠΌΡΡΠΎΠΏΠΎΠ΅ΡΠΈΡΠ½ΠΈΡ
ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΡΠΉ ΡΠΊΡΡΠΎ-ΡΠ°ΡΠΌΠ°ΡΡΡΠΊΠΈΡ
Ρ Π΄Π°Π²Π½ΡΠΎΡΡΡΡΠΊΠΈΡ
ΡΡΡΠΎΡΠ². ΠΠ²ΡΠΎΡΡΡΠΊΠ΅ ΠΏΡΠΎΡΠΈΡΠ°Π½Π½Ρ ΡΠ°ΠΊΡΠ°Π»ΡΠ½ΠΈΡ
, Π΅ΡΡΠ΅ΡΠΈΡΠ½ΠΈΡ
, ΡΡΠ½ΠΊΡΡΠΎΠ½Π°Π»ΡΠ½ΠΈΡ
Π·Π°Π²Π΄Π°Π½Ρ ΠΊΠΎΡΡΡΠΌΠ° ΡΡΠ°Π»ΠΎ, ΠΏΠΎ ΡΡΡΡ, ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΈΠΌ Π²ΡΡΠ»Π΅Π½Π½ΡΠΌ Π΄ΡΡ
ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΊΡΠ΅Π΄ΠΎ Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΡΡ, Π·ΡΠΎΠ±ΠΈΠ»ΠΎ ΠΌΠΎΠΆΠ»ΠΈΠ²ΠΈΠΌ ΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΠΏΠ°ΡΠ°Π»Π΅Π»Ρ Π· Π΄ΡΠ΅Π²Π½ΡΠΌΠΈ ΠΊΡΠ»ΡΡΡΡΠ°ΠΌΠΈ, ΡΠΎ Π²ΠΏΠ»ΠΈΠ½ΡΠ»ΠΈ Π½Π° ΡΠΎΡΠΌΡΠ²Π°Π½Π½Ρ ΠΌΠ΅Π³Π°ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΡ ΡΡΡΠ°ΡΠ½ΠΎΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ. ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· ΠΊΠΎΠ»Π΅ΠΊΡΡΡ ΠΊΠΎΡΡΡΠΌΡΠ² Π. Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ, ΡΠ°ΠΊΠΈΡ
ΡΠΊ Β«ΠΠ½ΡΠΆΠ° Π΄ΠΎΠ±Π°Β» ΡΠ° Β«Π‘ΠΊΡΡΡΡΠΊΠΈΠΉ ΡΡΠ΅ΠΏΒ», Π΄ΠΎΠ·Π²ΠΎΠ»ΠΈΠ² Π²ΠΈΡΠ²ΠΈΡΠΈ ΠΎΡΠΎΠ±Π»ΠΈΠ²ΠΎΡΡΡ Ρ
ΡΠ΄ΠΎΠΆΠ½ΡΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠ²ΡΡΠΎΡΠΏΡΠΈΠΉΠ½ΡΡΡΡ Π°Π²ΡΠΎΡΠ°, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΡΠΎΡΠΌΠ°Π»ΡΠ½ΠΈΡ
ΠΏΡΠΈΠΉΠΎΠΌΡΠ², Π²Π»Π°ΡΡΠΈΠ²ΠΈΠΉ ΡΡ Ρ
ΡΠ΄ΠΎΠΆΠ½ΡΠΉ ΠΌΠ°Π½Π΅ΡΡ. Π ΠΎΠ·Π³Π»ΡΠ΄Π°ΡΡΡΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΡΠΈΠ½ΡΠ΅Π·Ρ ΠΏΡΠΎΠ΅ΠΊΡΠ½ΠΎΠ³ΠΎ, ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ Ρ ΠΊΠΎΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠ΅Π½Π½Ρ ΡΡΡΠΎΡΠ², Π΄Π΅ Π. Π‘Π΅ΠΌΠΈΠΊΡΠ½Π° Π²ΠΈΡΡΡΠΏΠ°Ρ Π² ΡΠΏΠΎΡΡΠ°ΡΡΡ
ΡΠ΅ΠΎΡΠ΅ΡΠΈΠΊΠ°, Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΠΊΠ°, Π΄ΠΈΠ·Π°ΠΉΠ½Π΅ΡΠ°, ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΎΡ
ΠΡΠ½ΡΡΠ½Ρ ΠΌΠΎΡΠΈΠ²ΠΈ Π² ΠΊΠΎΡΡΡΠΌΠ°Ρ Π. Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ
This article is the result of an art research on the author series of costumes by the artist Lyudmila Semykina. The main focus of this study is semantics of mytho-poetic reconstructions of Scythian-Sarmatian and ancient costumes, performed by the author in 1960-1990. The problem of design, plastic and color solution synthesis is also raised, where L. Semykina acts in the role of theorist, artist, designer, constructor. Author's interpretation of the sacred, aesthetic and functional objectives of a costume was, in fact, the plastic embodiment of spiritual creed by the artist.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΡΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠΎΡΠΈΠ²Ρ Π² Π°Π²ΡΠΎΡΡΠΊΠΎΠΉ ΡΠ΅ΡΠΈΠΈ Π. Π‘Π΅ΠΌΡΠΊΠΈΠ½ΠΎΠΉ Β«Π‘ΠΊΠΈΡΡΠΊΠ°Ρ ΡΡΠ΅ΠΏΡΒ» (1960-1990 Π³Π³)., Π° ΡΠ°ΠΊΠΆΠ΅ ΡΡΠΎΡΠΌΡΠ»ΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈ ΠΊΠΎΠ»ΠΎΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΌΠΎΠ΄Π΅Π»Π΅ΠΉ. Π‘ΡΠΈΠ»ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΊΠΎΡΡΡΠΌΠΎΠ² Π. Π‘Π΅ΠΌΠΈΠΊΠΈΠ½ΠΎΠΉ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» Π²ΡΡΠ²ΠΈΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΈΡ
Ρ
ΡΠ΄ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΡΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ
ΠΏΡΠΈΠ΅ΠΌΠΎΠ², ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΡΠΈ ΡΠΎΠ·Π΄Π°Π½ΠΈΠΈ Π΄Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΈ.Π’Π΅ΠΌΠΎΡ Π΄Π°Π½ΠΎΡ ΡΡΠ°ΡΡΡ Ρ Π°Π½Π°Π»ΡΠ· Π΅ΡΠ½ΡΡΠ½ΠΈΡ
ΠΌΠΎΡΠΈΠ²ΡΠ² Π² Π΄ΠΈΠ·Π°ΠΉΠ½Π΅ΡΡΡΠΊΠΈΡ
ΠΌΠΎΠ΄Π΅Π»ΡΡ
ΠΎΠ΄ΡΠ³Ρ Π. Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ ΠΏΡΠ΄ Π½Π°Π·Π²ΠΎΡ Β«Π‘ΠΊΡΡΡΡΠΊΠΈΠΉ ΡΡΠ΅ΠΏΒ» (1960-1990 ΡΡ.). ΠΡΠ½ΠΎΠ²Π½ΠΈΠΌ Π½Π°ΠΏΡΡΠΌΠΊΠΎΠΌ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Ρ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠΎΠ»Ρ ΡΠ²ΠΎΡΡΠΈΡ
ΡΠΎΠ·ΡΠΎΠ±ΠΎΠΊ Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΡΡ Π² Π³Π°Π»ΡΠ·Ρ ΠΊΠΎΡΡΡΠΌΡ, ΡΠΊΠΈΠΉ ΡΠΎΠ·Π³Π»ΡΠ΄Π°ΡΡΡΡΡ Π°Π²ΡΠΎΡΠΎΠΌ ΡΠΊ ΡΠΈΠ½ΡΠ΅Π· ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ, ΠΎΡΠ½Π°ΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Ρ ΠΊΠΎΠ»ΡΠΎΡΠΎΠ²ΠΎΠ³ΠΎ ΡΡΡΠ΅Π½Π½Ρ. ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· ΠΊΠΎΠ»Π΅ΠΊΡΡΡ ΠΊΠΎΡΡΡΠΌΡΠ² Π. Π‘Π΅ΠΌΠΈΠΊΡΠ½ΠΎΡ, Π² ΡΠΊΡΠΉ Π²ΠΎΠ½Π° Π²ΠΈΡΡΡΠΏΠ°Ρ Π² ΡΠΏΠΎΡΡΠ°ΡΡΡ
Π΄ΠΈΠ·Π°ΠΉΠ½Π΅ΡΠ°, Ρ
ΡΠ΄ΠΎΠΆΠ½ΠΈΠΊΠ° Ρ ΡΠ΅ΠΎΡΠ΅ΡΠΈΠΊΠ°, Π΄ΠΎΠ·Π²ΠΎΠ»ΠΈΠ² Π²ΠΈΡΠ²ΠΈΡΠΈ ΠΎΡΠΎΠ±Π»ΠΈΠ²ΠΎΡΡΡ Ρ
ΡΠ΄ΠΎΠΆΠ½ΡΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠ²ΡΡΠΎΡΠΏΡΠΈΠΉΠ½ΡΡΡΡ Π°Π²ΡΠΎΡΠ°, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΡΠΎΡΠΌΠ°Π»ΡΠ½ΠΈΡ
ΠΏΡΠΈΠΉΠΎΠΌΡΠ², Π²Π»Π°ΡΡΠΈΠ²ΠΈΡ
ΡΡ Ρ
ΡΠ΄ΠΎΠΆΠ½ΡΠΉ ΠΌΠ°Π½Π΅ΡΡ
Recommended from our members
Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains
HIV-1 transgenic mice on the FVB/NJ background (TgFVB) represent a validated model of HIV-associated nephropathy (HIVAN). A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of nephropathy. We generated three sub-congenic strains carrying CAST alleles in the proximal or distal regions of the HIVAN1 locus (Sub-II, 3.02β38.93 Mb; Sub-III, 38.45β55.1 Mb and Sub-IV, 47.7β55.1 Mb, build 38). At 5β10 weeks of age, histologic injury and proteinuria did not differ between HIV-1 transgenic Sub-II and TgFVB mice. In contrast, HIV-1 transgenic Sub-III and Sub-IV mice displayed up to 4.4 fold more histopathologic injury and 6-fold more albuminuria compared to TgFVB mice, similar in severity to the full-length congenic mice. The Sub-IV segment defines a maximal 7.4 Mb interval for HIVAN1, and encodes 31 protein coding genes: 15 genes have missense variants differentiating CAST from FVB, and 14 genes show differential renal expression. Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy. HIVAN1 congenic kidneys are histologically normal without the HIV-1 transgene, yet their global transcriptome is enriched for molecular signatures of apoptosis, adenoviral infection, as well as genes repressed by histone H3 lysine 27 trimethylation, a histone modification associated with HIV-1 life cycle. These data refine HIVAN1to 7.4 Mb and identify latent molecular derangements that may predispose to nephropathy upon exposure to HIV-1
S-Nitrosylation of mitochondrial caspases
Caspase-3 is a cysteine protease located in both the cytoplasm and mitochondrial intermembrane space that is a central effector of many apoptotic pathways. In resting cells, a subset of caspase-3 zymogens is S-nitrosylated at the active site cysteine, inhibiting enzyme activity. During Fas-induced apoptosis, caspases are denitrosylated, allowing the catalytic site to function. In the current studies, we sought to identify the subpopulation of caspases that is regulated by S-nitrosylation. We report that the majority of mitochondrial, but not cytoplasmic, caspase-3 zymogens contain this inhibitory modification. In addition, the majority of mitochondrial caspase-9 is S-nitrosylated. These studies suggest that S-nitrosylation plays an important role in regulating mitochondrial caspase function and that the S-nitrosylation state of a given protein depends on its subcellular localization
Recommended from our members
A Retrotransposon Insertion in the 5' Regulatory Domain of Ptf1a Results in Ectopic Gene Expression and Multiple Congenital Defects in Danforthβs Short Tail Mouse
Danforth's short tail mutant (Sd) mouse, first described in 1930, is a classic spontaneous mutant exhibiting defects of the axial skeleton, hindgut, and urogenital system. We used meiotic mapping in 1,497 segregants to localize the mutation to a 42.8-kb intergenic segment on chromosome 2. Resequencing of this region identified an 8.5-kb early retrotransposon (ETn) insertion within the highly conserved regulatory sequences upstream of Pancreas Specific Transcription Factor, 1a (Ptf1a). This mutation resulted in up to tenfold increased expression of Ptf1a as compared to wild-type embryos at E9.5 but no detectable changes in the expression levels of other neighboring genes. At E9.5, Sd mutants exhibit ectopic Ptf1a expression in embryonic progenitors of every organ that will manifest a developmental defect: the notochord, the hindgut, and the mesonephric ducts. Moreover, at E 8.5, Sd mutant mice exhibit ectopic Ptf1a expression in the lateral plate mesoderm, tail bud mesenchyme, and in the notochord, preceding the onset of visible defects such as notochord degeneration. The Sd heterozygote phenotype was not ameliorated by Ptf1a haploinsufficiency, further suggesting that the developmental defects result from ectopic expression of Ptf1a. These data identify disruption of the spatio-temporal pattern of Ptf1a expression as the unifying mechanism underlying the multiple congenital defects in Danforth's short tail mouse. This striking example of an enhancer mutation resulting in profound developmental defects suggests that disruption of conserved regulatory elements may also contribute to human malformation syndromes
Notch4 activation aggravates NF-ΞΊB-mediated inflammation in HIV-1-associated nephropathy
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.Notch pathway activation plays a central role in the pathogenesis of many glomerular diseases. We have previously shown that Notch4 expression was upregulated in various renal cells in human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) patients and rodent models of HIVAN. In this study, we examined whether the Notch pathway can be distinctly activated by HIV-1 gene products and whether Notch4, in particular, can influence disease progression. Using luciferase reporter assays, we did not observe activation of the NOTCH4 promoter with the HIV protein Nef in podocytes. Further, we observed upregulated expression of a gamma secretase complex protein, presenilin 1, but not Notch4, in podocytes infected with an HIV-1 expression construct. To assess the effects of Notch4 on HIVAN disease progression, we engineered Tg26 mice with global deletion of the Notch4 intracellular domain (Notch4dl), which is required for signaling function. These mice (Notch4d1/Tg26+) showed a significant improvement in renal function and a significant decrease in mortality compared to Tg26 mice. Histological examination of kidneys showed that Notch4d1/Tg26+ mice had overall glomerular, tubulointerstitial injury and a marked decrease in interstitial inflammation. A significant decrease in the proliferating cells was observed in the tubulointerstitial compartments of Notch4d1/Tg26+ mice. Consistent with the diminished inflammation, kidneys from Notch4d1/Tg26+ mice also showed a significant decrease in expression of the inflammatory cytokine transcripts Il-6 and Ccl2, as well as the master inflammatory transcription factor NF-ΞΊB (Nfkb1 transcripts and p65 protein). These data identify Notch4 as an important mediator of tubulointerstitial injury and inflammation in HIVAN and a potential therapeutic target.National Institutes of Health (R01DK108433 awarded to M.S.
Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain
Chronic renal fibrosis is the final common pathway of end stage renal disease caused by glomerular or tubular pathologies. Genetic background has a strong influence on the progression of chronic renal fibrosis. We recently found that Rowett black hooded rats were resistant to renal fibrosis. We aimed to investigate the role of sustained inflammation and oxidative/nitrative stress in renal fibrosis progression using this new model. Our previous data suggested the involvement of podocytes, thus we investigated renal fibrosis initiated by doxorubicin-induced (5 mg/kg) podocyte damage. Doxorubicin induced progressive glomerular sclerosis followed by increasing proteinuria and reduced bodyweight gain in fibrosis-sensitive, Charles Dawley rats during an 8-week long observation period. In comparison, the fibrosis-resistant, Rowett black hooded rats had longer survival, milder proteinuria and reduced tubular damage as assessed by neutrophil gelatinase-associated lipocalin (NGAL) excretion, reduced loss of the slit diaphragm protein, nephrin, less glomerulosclerosis, tubulointerstitial fibrosis and matrix deposition assessed by periodic acid-Schiff, Picro-Sirius-red staining and fibronectin immunostaining. Less fibrosis was associated with reduced profibrotic transforming growth factor-beta, (TGF-beta1) connective tissue growth factor (CTGF), and collagen type I alpha 1 (COL-1a1) mRNA levels. Milder inflammation demonstrated by histology was confirmed by less monocyte chemotactic protein 1 (MCP-1) mRNA. As a consequence of less inflammation, less oxidative and nitrative stress was obvious by less neutrophil cytosolic factor 1 (p47phox) and NADPH oxidase-2 (p91phox) mRNA. Reduced oxidative enzyme expression was accompanied by less lipid peroxidation as demonstrated by 4-hydroxynonenal (HNE) and less protein nitrosylation demonstrated by nitrotyrosine (NT) immunohistochemistry and quantified by Western blot. Our results demonstrate that mediators of fibrosis, inflammation and oxidative/nitrative stress were suppressed in doxorubicin nephropathy in fibrosis-resistant Rowett black hooded rats underlying the importance of these pathomechanisms in the progression of renal fibrosis initiated by glomerular podocyte damage
A monoclonal antibody raised against bacterially expressed MPV17 sequences shows peroxisomal, endosomal and lysosomal localisation in U2OS cells
Recessive mutations in the MPV17 gene cause mitochondrial DNA depletion syndrome, a fatal infantile genetic liver disease in humans. Loss of function in mice leads to glomerulosclerosis and sensineural deafness accompanied with mitochondrial DNA depletion. Mutations in the yeast homolog Sym1, and in the zebra fish homolog tra cause interesting, but not obviously related phenotypes, although the human gene can complement the yeast Sym1 mutation. The MPV17 protein is a hydrophobic membrane protein of 176 amino acids and unknown function. Initially localised in murine peroxisomes, it was later reported to be a mitochondrial inner membrane protein in humans and in yeast. To resolve this contradiction we tested two new mouse monoclonal antibodies directed against the human MPV17 protein in Western blots and immunohistochemistry on human U2OS cells. One of these monoclonal antibodies showed specific reactivity to a protein of 20 kD absent in MPV17 negative mouse cells. Immunofluorescence studies revealed colocalisation with peroxisomal, endosomal and lysosomal markers, but not with mitochondria. This data reveal a novel connection between a possible peroxisomal/endosomal/lysosomal function and mitochondrial DNA depletion
Mutations in DSTYK and dominant urinary tract malformations.
ABSTRACT
Introduction
Congenital abnormalities of the kidney of the urinary tract are the most common cause of pediatric kidney failure. These disorders are highly heterogeneous, and their etiology is poorly understood.
Methods
We performed genome-wide linkage analysis and whole-exome sequencing in a family with autosomal dominant congenital abnormalities of the kidney of the urinary tract (7 affected family members). We also performed sequence analysis in 311 unrelated patients, as well as histologic and functional studies.
Results
Linkage analysis identified five regions of the genome that were shared among all affected family members. Exome sequencing identified a single rare deleterious variant within these linkage intervals, a heterozygous splice-site mutation in dual serine/threonine and tyrosine protein kinase (DSTYK). This variant, which resulted in aberrant gene product splicing, was present in all affected family members. Additional independent DSTYK mutations, including nonsense and splice-site mutations, were detected among 7/311 unrelated patients. DSTYK is highly expressed in the maturing epithelia of all major organs, localizing to cell membranes. Knockdown in zebrafish resulted in multi-organ developmental defects, resembling loss of fibroblast growth factor (FGF) signaling. Consistent with this finding, DSTYK colocalizes with FGF receptors in the ureteric bud and metanephric mesenchyme. Finally, DSTYK knockdown in human embryonic kidney cells inhibited FGF-stimulated ERK-phosphorylation, the principal signal downstream of receptor tyrosine kinases.
Conclusions
We detected DSTYK mutations in 2.2% of patients with congenital abnormalities of the kidney and urinary tract whom we studied, suggesting that DSTYK is a major determinant of human urinary tract development, downstream of FGF signaling
- β¦